ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vivacelle Bio Receives Award from Navy for VBI-S Trial for Hypovolemia of Septic Shock Due to COVID
December 10, 2020Vivacelle Bio announces the Department of Defense awarded $5.3 million dollars for the clinical trial of VBI-S, an intravenously injected fluid based upon Vivacelle Bio's phospholipid nanoparticle technology for the treatment of septic shock due to ... -
Vivacelle Bio Receives FDA Clearance to Enroll Patients into its Phase IIa Trial of VBI-1
February 18, 2019Vivacelle Bio announced the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and ....
Pharma Sources Insight January 2025
